Archive for the ‘
Social media in pharma ’ Category
Thursday, July 28th, 2011
Shortly after I posted Lessons from the Pfizer Facebook hack, I was intrigued to see a number of folks on Twitter clucking over a quote from Bruce Grant, senior VP, business strategy, at Digitas Health:
"Our advice is you don’t have a choice as to whether you have a page – ...
Posted in
Social media in pharma |
No Comments »
Wednesday, July 20th, 2011
That mischievous splinter sect of Anonymous, The Script Kiddies, has been at it again; first they made a name for themselves by hacking Fox News' Twitter feed and sending out reports of President Obama's death. Now the group has turned its sights to Big Pharma, hacking Pfizer's Facebook page (the ...
Posted in
Patient education, Pharmaceutical operations, Social media in pharma, Technology |
6 Comments »
Wednesday, July 13th, 2011
Sermo has taken crowdsourcing to a whole new level with the launch today of its mobile app for physicians, Sermo Mobile. Physicians can download Sermo Mobile for free at www.sermo.com/mobile. The app features iConsult, a way for physicians to quickly share information from the patient bedside and get opinions from ...
Posted in
Professional education, Promotional medical education, Social media in pharma, Technology, physicians |
2 Comments »
Tuesday, June 21st, 2011
With the quickly approaching Aug. 15 deadline for allowing comments on their Facebook walls, pharmaceutical companies are grappling with whether to leave this area of social media all together. Intouch Solutions examined the dilemma and came up with their own solution for pharma: PharmaWall, a Facebook monitoring and moderation tool.
"Facebook’s ...
Posted in
Legal actions, Pharmaceutical operations, Professional education, Promotional medical education, Social media in pharma |
No Comments »
Wednesday, April 27th, 2011
AstraZeneca has finally done what non-pharma companies such as Amazon, BestBuy, Clairol, and Comcast have been doing for years now. For patients who don't want to call an 800-number, AstraZeneca has unveiled an online chat function for its its cholesterol medication Crestor and the heartburn drug Nexium (click the product ...
Posted in
Patient education, Pharmaceutical operations, Promotional medical education, Social media in pharma, disease awareness |
No Comments »
Thursday, April 14th, 2011
There is no doubt that the pharma industry is a little bit in love with the iPad, especially sales representatives. Unlike the previous, PC-based generation of tablet computers, the things actually work and have battery power that can be measured in hours, not minutes. Truthfully, anyone who gets to play ...
Posted in
Professional education, Sales force effectiveness, Social media in pharma, Technology |
2 Comments »
Wednesday, April 13th, 2011
I just got back onto Twitter after quite a number of weeks of minimal involvement. The heartwarming thing is I got quite a few private messages asking me if I was all right. I'm fine. All of us here have been involved in preparing the huge April issue and preparing ...
Posted in
Manny Awards, Patient education, Promotional medical education, Social media in pharma, disease awareness |
No Comments »
Tuesday, March 8th, 2011
(This is a guest post by Ed Silverman of Pharmalot.)
Last fall, Pfizer began running ads for Lipitor that prominently touted the notion that exercise and a healthy diet may not make enough of a difference for two out of three people who must lower their cholesterol. To make its point, ...
Posted in
Patient education, Promotional medical education, Social media in pharma |
No Comments »
Wednesday, February 9th, 2011
(This blog post by Leigh Householder and Ben Harben of GSW Worldwide is being reposted with their permission)
Gaming is a big part of American life. Last year, 50% of households gamed often. Most chose that gaming time over some other media or entertainment. Those immersive, entertaining, often all-encompassing games change ...
Posted in
Patient education, Social media in pharma, Technology, e-Marketing |
5 Comments »
Friday, December 3rd, 2010
I had lunch this week in New York with three of my editorial board members; Diane Krusko of Pfizer, Michael Thyens of Eli Lilly, and industry marketing powerhouse in his own right, Sander Flaum of Flaum Partners.
During the lunch, the topic was debated again about why pharma can't seem to ...
Posted in
Social media in pharma, Uncategorized |
1 Comment »
|
|
